Skip to main content

Advertisement

Log in

RETRACTED ARTICLE: HAX-1 Promotes the Chemoresistance, Invasion, and Tumorigenicity of Esophageal Squamous Carcinoma Cells

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This article was retracted on 12 July 2019

This article has been updated

Abstract

Background

HAX-1 is an anti-apoptotic factor and regulates the expression of DNA pol β. Interestingly, DNA polymerase pol β is overexpressed in esophageal squamous cell carcinoma (ESCC). However, the functional role of HAX-1 in ESCC remains unclear.

Aims

To investigate the role of HAX-1 in chemoresistance, invasion, and tumorigenicity of ESCC.

Methods

Lentivirus-mediated overexpression or knockdown of HAX-1 was employed to establish ESCC EC9706 cell lines that expressed HAX-1 at different levels. The biological behaviors of these engineered cells were characterized in vitro and in vivo using a xenograft nude mice model. In addition, HAX-1 and pol β expression in the tumor tissues was detected by RT-PCR and immunohistochemistry.

Results

HAX-1 overexpression promoted cell proliferation and resistance against cisplatin, increased cell invasion and suppressed apoptosis along with increased pol β expression. Conversely, HAX-1 knockdown inhibited the malignant phenotypes of EC9706 cells. The xenograft nude mice model demonstrated that HAX-1 overexpression or depletion led to increased or decreased tumor growth in vivo, respectively. Furthermore, a positive correlation of HAX-1 and pol β expression in the tumor tissues was observed.

Conclusions

HAX-1 promotes the proliferation, chemoresistance, invasion, and tumorigenicity of ESCC, and this is correlated with increased poly β expression. HAX-1 may represent a potential target to overcome the resistance and metastasis of ESCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Change history

  • 12 July 2019

    The Editor-in-Chief has retracted this article [1] because Figure 3c appears to have been modified and reused as Figure 3d.

  • 12 July 2019

    The Editor-in-Chief has retracted this article [1] because Figure��3c appears to have been modified and reused as Figure��3d.

References

  1. Pisani P, Parkin DM, Bray F, et al. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;83:18–29.

    Article  CAS  Google Scholar 

  2. Lehrbach DM, Nita ME, Cecconello I. Molecular aspects of esophageal squamous cell carcinoma carcinogenesis. Arq Gastroenterol. 2003;40:256–261.

    Article  Google Scholar 

  3. Zheng X, Zhao Y, Wang X, et al. Decreased expression of CIAPIN1 is correlated with poor prognosis in patients with esophageal squamous cell carcinoma. Dig Dis Sci. 2010;55:3408–3414.

    Article  CAS  Google Scholar 

  4. Ren HZ, Pan GQ, Wang JS, et al. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma. Dig Dis Sci. 2010;55:2552–2560.

    Article  CAS  Google Scholar 

  5. Zhang H, Li M, Han Y, et al. Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma. Dig Dis Sci. 2010;55:2545–2551.

    Article  CAS  Google Scholar 

  6. Hu N, Wang C, Ng D, et al. Genomic characterization of esophageal squamous cell carcinoma from a high-risk population in China. Cancer Res. 2009;69:5908–5917.

    Article  CAS  Google Scholar 

  7. Bass AJ, Watanabe H, Mermel CH, et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet. 2009;41:1238–1242.

    Article  CAS  Google Scholar 

  8. Sobol R, Horton J, Kühn R, et al. Requirement of mammalian DNA polymerase beta in base-excision repair. Nature. 1996;379:183–186.

    Article  CAS  Google Scholar 

  9. Srivastava DK, Husain I, Arteaga CL, et al. DNA polymerase beta expression differences in selected human tumors and cell lines. Carcinogenesis. 1999;20:1049–1054.

    Article  CAS  Google Scholar 

  10. Canitrot Y, Hoffmann JS, Calsou P, et al. Nucleotide excision repair DNA synthesis by excess DNA polymerase beta: a potential source of genetic instability in cancer cells. FASEB J. 2000;14:1765–1774.

    Article  CAS  Google Scholar 

  11. Bergoglio V, Canitrot Y, Hogarth L, et al. Enhanced expression and activity of DNA polymerase beta in human ovarian tumor cells: impact on sensitivity towards antitumor agents. Oncogene. 2001;20:6181–6187.

    Article  CAS  Google Scholar 

  12. Dong ZM, Zheng NG, Wu JL, et al. Difference in expression level and localization of DNA polymerase beta among human esophageal cancer focus, adjacent and corresponding normal tissues. Dis Esophagus. 2006;19:172–176.

    Article  CAS  Google Scholar 

  13. Sarnowska E, Grzybowska EA, Sobczak K, et al. Hairpin structure within the 3′UTR of DNA polymerase beta mRNA acts as a post-transcriptional regulatory element and interacts with HAX-1. Nucleic Acids Res. 2007;35:5499–5510.

    Article  CAS  Google Scholar 

  14. Suzuki Y, Demoliere C, Kitamura D, et al. HAX-1, a novel intracellular protein, localized on mitochondria, directly associates with HS1, a substrate of Src family tyrosine kinases. J Immunol. 1997;158:2736–2744.

    CAS  PubMed  Google Scholar 

  15. Sharp TV, Wang HW, Koumi A, et al. K15 protein of Kaposi’s sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. J Virol. 2002;76:802–816.

    Article  CAS  Google Scholar 

  16. Han Y, Chen YS, Liu Z, et al. Overexpression of HAX-1 protects cardiac myocytes from apoptosis through caspase-9 inhibition. Circ Res. 2006;99:415–423.

    Article  CAS  Google Scholar 

  17. Cilenti L, Soundarapandian MM, Kyriazis GA, et al. Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death. J Biol Chem. 2004;279:50295–50301.

    Article  CAS  Google Scholar 

  18. Lee AY, Lee Y, Park YK, et al. HS 1-associated protein X-1 is cleaved by caspase-3 during apoptosis. Mol Cells. 2008;25:86–90.

    CAS  PubMed  Google Scholar 

  19. Vafiadaki E, Arvanitis DA, Pagakis SN, et al. The anti-apoptotic protein HAX-1 interacts with SERCA2 and regulates its protein levels to promote cell survival. Mol Biol Cell. 2009;20:306–318.

    Article  CAS  Google Scholar 

  20. Gallagher AR, Cedzich A, Gretz N, et al. The polycystic kidney disease protein PKD2 interacts with Hax-1, a protein associated with the actin cytoskeleton. Proc Natl Acad Sci USA. 2000;97:4017–4022.

    Article  CAS  Google Scholar 

  21. Radhika V, Onesime D, Ha JH, et al. Galpha13 stimulates cell migration through cortactin-interacting protein Hax-1. J Biol Chem. 2004;279:49406–49413.

    Article  CAS  Google Scholar 

  22. Ramsay AG, Keppler MD, Jazayeri M, et al. HS1-associated protein X-1 regulates carcinoma cell migration and invasion via clathrin-mediated endocytosis of integrin αvβ6. Cancer Res. 2007;67:5275–5284.

    Article  CAS  Google Scholar 

  23. Yan S, Zhou C, Lou X, et al. PTTG overexpression promotes lymph node metastasis in human esophageal squamous cell carcinoma. Cancer Res. 2009;69:3283–3290.

    Article  CAS  Google Scholar 

  24. Naldini L, Blomer U, Glay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996;272:263–267.

    Article  CAS  Google Scholar 

  25. Matsuda G, Nakajima K, Kawaguchi Y, et al. Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) forms complexes with a cellular anti-apoptosis protein Bcl-2 or its EBV counterpart BHRF1 through HS1-associated protein X-1. Microbiol Immunol. 2003;47:91–99.

    Article  CAS  Google Scholar 

  26. Stewart SA, Dykxhoorn DM, Palliser D, et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA. 2003;9:493–501.

    Article  CAS  Google Scholar 

  27. Simmen T. Hax-1: a regulator of calcium signaling and apoptosis progression with multiple roles in human disease. Expert Opin Ther Targets. 2011;15:741–751.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

We thank Dr. Zhi Huijun (NIH) for providing plasmids p∆8.2 and pVSV-G. We thank Biomedworld for providing a manuscript editing service.

Conflict of interests

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zi-ming Dong.

Additional information

The Editor-in-Chief has retracted this article because Figure 3c appears to have been modified and reused as Figure 3d. An investigation by Zhengzhou University has confirmed that this figure was modified and reused. The data reported in this article are therefore unreliable. None of the authors has responded to any correspondence from the editor and the publisher about this retraction.

About this article

Cite this article

Sun, Sj., Feng, L., Zhao, Gq. et al. RETRACTED ARTICLE: HAX-1 Promotes the Chemoresistance, Invasion, and Tumorigenicity of Esophageal Squamous Carcinoma Cells. Dig Dis Sci 57, 1838–1846 (2012). https://doi.org/10.1007/s10620-012-2108-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-012-2108-5

Keywords

Navigation